Report : North America Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), Allergy type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Geography
Sublingual Immunotherapy (SLIT) segment by treatment is estimated to lead the market growth during the forecast period
According to The Insight Partners market research study of “North America Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment, Allergy type and Distribution Channel,” The North America allergy immunotherapies market was valued at US$ 697.53 million in 2019 and is projected to reach US$ 1,634.17 million by 2027; it is expected to grow at a CAGR of 11.3 % during the forecast period. This can be attributed to the increasing developments in the healthcare sector. The rising initiatives by various research institutes and organizations for improving medical facilities and services are further leading to the market growth.
Based on the treatment, the North America allergy immunotherapies market is further segmented into the the SCIT segment held a larger share of the market in 2079. However, the SLIT segment is expected to grow at a higher CAGR during the forecast period. Allergen immunotherapy is a medical treatment useful for environmental allergies, insect bite allergies, and asthma. Positive results of various immunotherapies that are in clinical trials encourage the development activities of allergy immunotherapy-based drugs. Thus, growing prevalence of different allergies and increasing drug development activities boost the North America allergy immunotherapies market growth. The market players are also adopting business expansion, collaboration, and new product development strategies to increase their market footprint.
The American Academy of Allergy, Asthma & Immunology, Celsion Corporation, the US Food and Drug Administration (FDA), and World Allergy Organization (WAO) are among the leading companies operating in the North America allergy immunotherapies market.
The report segments North America Allergy Immunotherapies Market as follows:
By Allergy Type
By Distribution Channel